Liver-Kidney Crosstalk in Major Pediatric Diseases: Unraveling the Complexities and Clinical Challenges

• Published in: Journal of clinical medicine Vol. 14; no. 11; p. 3911
• Main Authors: Piatto, Dario, De Biasio, Delia, Cesaro, Francesco Giustino, Forcina, Gianmario, Frattolillo, Vittoria, Colucci, Antonio, Lamberti, Fabio, Marzuillo, Pierluigi, Miraglia del Giudice, Emanuele, Di Sessa, Anna
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02.06.2025; MDPI
• Subjects: Adults; Analysis; Care and treatment; Children; Copper; Cytokines; Development and progression; Diabetes; Diagnosis; Diseases; Fatty liver; Genetic disorders; Hepatitis; Hypertension; Inflammation; Kidney diseases; Liver; Liver cancer; Liver cirrhosis; Liver diseases; Liver transplants; Metabolic diseases; Metabolism; Mutation; Obesity; Oxidative stress; Pathophysiology; Pediatrics; Physiology, Pathological; Review; Risk factors; Sepsis; Thyroid gland; Tumor necrosis factor-TNF; Type 2 diabetes; Italy; kidney; crosstalk; challenges; liver; management; hepatorenal syndrome; pediatric diseases; metabolic dysfunction-associated steatotic liver disease
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm14113911

The liver and kidneys are two of the most vital organs, each with distinct but overlapping functions essential for maintaining homeostasis. The complex interplay between these organs, commonly referred to as liver-kidney crosstalk, plays a crucial role in the pathophysiology of several acute and chronic conditions in childhood. Despite its importance, the precise biological mechanisms driving this interaction remain incompletely understood. This crosstalk is particularly significant in various pediatric diseases (e.g., Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Hepatorenal Syndrome (HRS), genetic and metabolic disorders, etc.) where shared pathophysiological factors—including systemic inflammation, metabolic disturbances, oxidative stress, and vascular dysfunction—simultaneously affect both organs. Clinically, this interaction presents unique challenges in diagnosing, managing, and treating liver-kidney diseases in affected children. Understanding the pathogenic mechanisms underlying liver-kidney crosstalk is essential for improving patient care and outcomes through an integrated, multidisciplinary approach and personalized treatment strategies. This review aims to explore liver-kidney crosstalk in key pediatric diseases, offering a comprehensive overview of current knowledge, clinical challenges, and potential therapeutic interventions in this complex field.